Le Lézard
Classified in: Health
Subjects: RCL, PSF

CPSC Report Finds 37 Percent Spike in Child Poisoning Deaths in 2021


WASHINGTON, March 20, 2023 /PRNewswire/ -- Unintentional pediatric poisoning deaths spiked 37 percent in 2021, with 59 children under five years old losing their lives after gaining access to prescribed or illicit drugs. The U.S. Consumer Product Safety Commission (CPSC) encourages consumers to safeguard their families, especially those more vulnerable, from poisonings by taking control of potentially harmful household products, medications and drugs.

This National Poison Prevention Week (March 20-24, 2023) marks 61 years since the first national observation. Child poisoning deaths have fallen by 73 percent since 1972 due to tough federal laws including the Poison Prevention Packaging Act (PPPA) of 1970 and the Child Nicotine Poisoning Prevention Act of 2015 and the cooperation of the poison prevention community. This community includes the American Association of Poison Control Centers, standard development organizations, consumer advocates, medical professionals, industry and government.

"Sadly, this report shows the work that still needs to be done to protect children," said Alexander Hoehn-Saric, Chair of the U.S. Consumer Product Safety Commission. "Nearly eight out of 10 poisonings occurred in the home. Please take the time to store cleaning supplies, laundry packets, button batteries, and drugs out of children's reach or in locked cabinets.  If you see it lying around, a child can grab and swallow it."

CPSC's latest report notes that African American children suffer a higher rate of unintentional pediatric poisoning injuries, 21.4 percent, compared to being 15.8 percent of the U.S. population. The report also found that blood pressure medications, acetaminophen, antidepressants, laundry packets and bleach are the five products most involved in unintentional pediatric poisonings.

CPSC encourages family members and caregivers to identify hazards in the home that could be a poisoning danger and keep them out of a child's sight and reach.

Safety tips for parents and caregivers:

Drugs or Medications

Laundry Packets

Household Cleaning Supplies

Button Cell or Coin Batteries

Individual Commissioners may have statements related to this topic.  Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.

About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.

For lifesaving information:
- Visit CPSC.gov.
- Sign up to receive our e-mail alerts.
- Follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC
- Report a dangerous product or a product-related injury on www.SaferProducts.gov.
- Call CPSC's Hotline at 800-638-2772 (TTY 301-595-7054).
- Contact a media specialist

Release Number: 23-162

 

SOURCE U.S. Consumer Product Safety Commission


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: